Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- CheckyesterdayChange DetectedAdded a global notice about government funding lapse and NIH Clinical Center operating status with links to cc.nih.gov and opm.gov. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a glossary display option and a QC-status indicator; updated the page revision to v3.4.0 and adjusted capitalization of No FEAR Act terms.SummaryDifference0.2%

- Check15 days agoChange DetectedA large number of core terms and sections central to the study record have been deleted, including disease names, treatments, eligibility criteria, location details, and investigators. This reduces the page's clarity and navigability.SummaryDifference17%

- Check22 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a Locations section with a new site in Seattle, Washington. Washington is now listed as a study location.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page footer revision updated from v3.3.1 to v3.3.2; no other sections of the study details were altered.SummaryDifference0.1%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.